Want to join the conversation?
$ICPT 2Q15 Call: We will be evaluating Regenerate two doses 10mg and 25mg given once daily. Recalled that 25mg dose was the dose studied in FLINT. Our decision to add a 10mg lower dose in the phase III study was based on our experience in PBC. In our phase II PBC studies we found that doses higher than 10mg conferred no additional efficacy.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.